arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Cardiol Therapeutics Inc.

CRDL Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$1.12
▼ -4.3% Today
as of Oct 23, 16:47 ET
Last 30 days -43.72% Sep 14 → Oct 23
$1.03 $1.29 $1.55 $1.80 $2.06 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$1.16
High
$1.19
Low
$1.15
Volume
$443,337
Avg Vol
$769,642
Mkt Cap
$189M
P/E (TTM)
—
Beta
—
52w High
$2.34
52w Low
$0.88
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 8 items

Sep 23 · 10:00 CNW Group
Cardiol Therapeutics Achieves Phase III MAVERIC Enrollment Target Ahead of Schedule and Expands Pivotal Trial to Strengthen Assessment of CardiolRx™'s Efficacy
Sep 23 · 10:00 PR PR Newswire
Cardiol Therapeutics Achieves Phase III MAVERIC Enrollment Target Ahead of Schedule and Expands Pivotal Trial to Strengthen Assessment of CardiolRx™'s Efficacy
Sep 16 · 11:27 CNW Group
Cardiol Therapeutics Announces Warrant Exercise for Over USD $7 Million in Proceeds
▸ Show all 8 press releases & news Free account →

CRDL earnings at a glance

The options market is pricing a move of about ±8.1% after the report, a range of roughly $1.03 to $1.21 from today's $1.12. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±2.1% on average; after the most recent report on May 11, 2026 it moved +1.1%. That means options currently expect more movement than CRDL has typically delivered. CRDL beat the consensus EPS estimate in 2 of its last 4 reported quarters. Implied volatility is currently 39%. The share price of $1.12 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$0.88
$2.34
16% of range
Avg surprise (last 4)
+14.6%
Avg reaction (last 2)
-1.0%
50% positive
Latest IV / EM
39%
EM ±8.1% · $3 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.61$-0.35$-0.09$0.17$0.43 Actual $-0.07Est $-0.09Actual $-0.07Est $-0.11Actual $-0.09Est $-0.09Actual $-0.07Est $-0.07 Mar/2025Jun/2025Sep/2025Mar/2026

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Mon May 11, 2026Mar/2026 $-0.07 $-0.07 0.0% 0.0% +1.1% earnings
Thu Nov 13, 2025Sep/2025 $-0.09 $-0.09 0.0% — — earnings
Thu Aug 14, 2025Jun/2025 $-0.07 $-0.11 +36.4% — — earnings
Wed May 14, 2025Mar/2025 $-0.07 $-0.09 +22.2% — -3.1% earnings

Implied volatility — last 90 days

36%1121%2206%3291%4376% Jun 10 — IV 3699% · EM ±436.9%Jun 11 — IV 3906% · EM ±431.6%Jun 12 — IV 4299% · EM ±439.8%Jul 02 — IV 3062% · EM ±495.2%Jul 03 — IV 3169% · EM ±495.2%Jul 06 — IV 1923% · EM ±266.4%Jul 08 — IV 2355% · EM ±295.0%Aug 25 — IV 37% · EM ±7.5%Aug 26 — IV 70% · EM ±14.0%Aug 27 — IV 74% · EM ±14.6%Aug 28 — IV 75% · EM ±14.4%Aug 31 — IV 43% · EM ±7.6%Sep 01 — IV 68% · EM ±11.6%Sep 02 — IV 69% · EM ±11.5%Sep 03 — IV 71% · EM ±11.5%Sep 04 — IV 73% · EM ±11.4%Sep 07 — IV 82% · EM ±11.4%Sep 09 — IV 70% · EM ±8.8%Sep 10 — IV 83% · EM ±9.8%Sep 16 — IV 3119% · EM ±184.2%Sep 17 — IV 4377% · EM ±182.8%Sep 21 — IV 39% · EM ±8.1%

Sector peers

CMPX
Compass Therapeutics, Inc.
$184M $0.76-6.6%
DTIL
Precision BioSciences, Inc.
$173M $6.64-1.0%
IPHA
Innate Pharma S.A.
$208M $1.50-4.5%
VYGR
Voyager Therapeutics, Inc.
$165M $1.74-13.9%
OTLK
Outlook Therapeutics, Inc.
$165M $0.52-7.4%
ALEC
Alector, Inc.
$214M $1.83-2.1%

CRDL earnings FAQ

What is CRDL's expected move for earnings?

Options currently price a move of about ±8.1%, or $0.09 per share either way from $1.12.

How does CRDL stock usually react to earnings?

Across the last 2 reports the average next-day move was ±2.1%, up 1 times and down 1 times.

What is CRDL's implied volatility?

CRDL's at-the-money implied volatility is about 39% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in